The difference between a missed diagnosis and an informed clinical decision for patients living with uncommon and frequently overlooked conditions may come down to whether their health care provider recognizes the need to investigate further. At The France Foundation (TFF), we understand that educating clinicians about rare and complex diseases requires a specialized approach. It means identifying critical gaps in clinical knowledge, working alongside experts who understand the nuances of these conditions, and developing focused education that equips health care professionals to apply what they've learned in practice.

Our recently launched activity, Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis, demonstrates how this approach can bring highly specialized medical knowledge to the clinicians and patients who stand to benefit most.

Recognizing What Others May Overlook

When it comes to rare diseases, while the underlying cause is often readily identifiable, some patients require a more detailed diagnostic investigation.

For example, hypoparathyroidism is characterized by insufficient parathyroid hormone activity, which can lead to low calcium levels and significant health complications. Among the conditions clinicians must consider is autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder that can be overlooked during the evaluation of hypoparathyroidism. Identifying ADH1 matters because understanding the underlying genetic cause can influence clinical management and carry implications beyond the individual patient, including for family members who may share the condition.

Knowing when to suspect the condition and how to appropriately incorporate genetic testing into the diagnostic process is an important skill for clinicians who may rarely encounter ADH1. It’s the rarity of the disease that limits opportunities to develop that expertise in everyday clinical experience. This educational challenge is exactly what TFF is equipped to address.

Translating Specialized Knowledge Into Clinical Confidence

Rather than attempting to cover every aspect of a complex disease, the education concentrates on the clinical decisions most relevant to identifying patients who may benefit from further evaluation. Developed with Dolores Shoback, MD, of the University of California, San Francisco, and Michael Collins, MD, of the National Institutes of Health, the activity focuses on helping endocrinologists and other members of the endocrine care team recognize ADH1 as a potential cause of hypoparathyroidism. Participants explore the importance of considering ADH1 in the differential diagnosis, appropriate diagnostic strategies and genetic testing considerations, and how to communicate the role of genetic testing to patients.

This focused approach reflects an important principle in TFF's educational strategy: effective education isn't necessarily about delivering more information, but delivering the right information to the right clinicians, in a form they can use. Rare disease education presents challenges that extend beyond clinical complexity. Smaller patient populations, limited opportunities for firsthand experience, and highly specialized diagnostic considerations can make it difficult for clinicians to develop and maintain familiarity with uncommon conditions. By concentrating on a specific diagnostic challenge, our activities support the practical skills clinicians need to recognize when a familiar presentation may have an uncommon explanation.

Making an Impact Where It Matters Most

For rare diseases, educational impact cannot be measured by audience size alone. Reaching a clinician who can recognize an overlooked diagnosis, initiate an appropriate evaluation, or help a patient understand the implications of genetic testing represents an important opportunity to improve care. In the context of our ADH1 initiative, it illustrates the value of targeted continuing education and our ability to bring attention to clinical challenges that might otherwise receive limited educational focus.

As scientific understanding and diagnostic capabilities continue to advance, the need for specialized education will only grow. The France Foundation remains focused on connecting complex science with the health care professionals who can put it to use, because when a disease is exceptionally rare, getting the right knowledge into the right hands matters all the more.